In vivo flow cytometry determined that MDK-siRNA was capable of suppressing M2 polarization of TAMs and reducing the proportion of MDSCs (CD11b + Gr+) in mice bearing orthotopic HCC (Fig. 5A). This evidence concerns the gene MDK and hepatocellular carcinoma.